{"abstract":"The Food and Drug Administration (FDA) is announcing a public meeting and scientific workshop, both of which will provide an opportunity for public comment on the topic of Female Sexual Interest/ Arousal Disorder (FSIAD), the most common form of female sexual dysfunction. FSIAD is a diagnosis that combines two previously distinct disorders--hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder (FSAD). The public meeting will take place on October 27, 2014, and is part of FDA's Patient-Focused Drug Development performance commitments made as part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V). At this meeting, FDA will obtain patients' perspectives on the impact that FSIAD (or a prior diagnosis of HSDD or FSAD) has on their daily lives, as well as their perspectives on the available therapies for these conditions. The scientific workshop will take place on October 28, 2014, and will provide an opportunity for FDA to seek input from experts on scientific issues important to the clinical development of drug products intended to treat FSIAD.","action":"Notice of public meeting and workshop; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/09/26/2014-22983.html","cfr_references":[],"citation":"79 FR 57942","comment_url":null,"comments_close_on":"2014-12-29","correction_of":null,"corrections":[],"dates":"The meeting will be held on October 27, 2014, from 12 p.m. to 5 p.m. and the workshop will be held on October 28, 2014, from 8 a.m. to 5 p.m. Registration to attend either the meeting or the workshop must be received by October 17, 2014. See the SUPPLEMENTARY INFORMATION section for information on how to register for either the meeting or the workshop. Submit electronic or written comments by December 29, 2014.","disposition_notes":null,"docket_ids":["Docket No. FDA-2014-N-1413"],"dockets":[],"document_number":"2014-22983","effective_on":null,"end_page":57944,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/09/26/2014-22983.xml","html_url":"https://www.federalregister.gov/documents/2014/09/26/2014-22983/patient-focused-drug-development-public-meeting-and-scientific-workshop-on-female-sexual-dysfunction","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-22983?publication_date=2014-09-26","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-09-26/2014-22983/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":486,"last_updated":"2026-07-26 16:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-09-26/pdf/2014-22983.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-22983.pdf?1411649077","publication_date":"2014-09-26","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/09/26/2014-22983.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2014-N-1413","supporting_documents_count":0,"docket_id":"FDA-2014-N-1413","regulation_id_number":null,"title":"Patient-Focused Drug Development Public Meeting and Scientific Workshop on Female Sexual Dysfunction","checked_regulationsdotgov_at":"2014-12-30T05:00:48Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":57942,"subtype":null,"title":"Patient-Focused Drug Development Public Meeting and Scientific Workshop on Female Sexual Dysfunction","toc_doc":"Patient-Focused Drug Development and Scientific Workshop on Female Sexual Dysfunction","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":79}